The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses - PubMed (original) (raw)
The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses
R K Naviaux et al. J Virol. 1996 Aug.
Abstract
We describe the construction and characterization of retroviral vectors and packaging plasmids that produce helper-free retrovirus with titers of 1 X 10(6) to 5 X 10(6) within 48 h. These vectors contain the immediate early region of the human cytomegalovirus enhancer-promoter fused to the Moloney murine leukemia virus long terminal repeat at the TATA box in the 5' U3 region, yielding the pCL promoter. By selecting vectors designed to express genes from one of four promoters (dihydrofolate reductase, Rous sarcoma virus, long terminal repeat, or cytomegalovirus), the pCL system permits the investigator to control the level of gene expression in target cells over a 100-fold range, while maintaining uniformly high titers of virus from transiently transfected producer cells. The pCL packaging plasmids lack a packaging signal (delta-psi) and include an added safety modification that renders them self-inactivating through the deletion of the 3' U3 enhancer. Ecotropic, amphotropic (4070A), and amphotropic-mink cell focus-forming hybrid (10A1) envelope constructions have been prepared and tested, permitting flexible selection of vector pseudotype in accordance with experimental needs. Vector supernatants are free of helper virus and are of sufficiently high titer within 2 days of transient transfection in 293 cells to permit infection of more than 50% of randomly cycling target cells in culture. We demonstrated the efficacy of these vectors by using them to transfer three potent cell cycle control genes (the p16(INK4A), p53, and Rb1 genes) into human glioblastoma cells.
Similar articles
- Safe and efficient ecotropic and amphotropic packaging lines for use in gene transfer experiments.
Markowitz DG, Goff SP, Bank A. Markowitz DG, et al. Trans Assoc Am Physicians. 1988;101:212-8. Trans Assoc Am Physicians. 1988. PMID: 3077729 - Episomal vectors rapidly and stably produce high-titer recombinant retrovirus.
Kinsella TM, Nolan GP. Kinsella TM, et al. Hum Gene Ther. 1996 Aug 1;7(12):1405-13. doi: 10.1089/hum.1996.7.12-1405. Hum Gene Ther. 1996. PMID: 8844199 - Large-scale manufacturing of safe and efficient retrovirus packaging lines for use in immunotherapy protocols.
Farson D, McGuinness R, Dull T, Limoli K, Lazar R, Jalali S, Reddy S, Pennathur-Das R, Broad D, Finer M. Farson D, et al. J Gene Med. 1999 May-Jun;1(3):195-209. doi: 10.1002/(SICI)1521-2254(199905/06)1:3<195::AID-JGM31>3.0.CO;2-#. J Gene Med. 1999. PMID: 10738568 - High-efficiency gene transfer into mammalian cells: generation of helper-free recombinant retrovirus with broad mammalian host range.
Cone RD, Mulligan RC. Cone RD, et al. Proc Natl Acad Sci U S A. 1984 Oct;81(20):6349-53. doi: 10.1073/pnas.81.20.6349. Proc Natl Acad Sci U S A. 1984. PMID: 6093098 Free PMC article. - Stable expression of the ecotropic retrovirus receptor in amphotropic packaging cells facilitates the transfer of recombinant vectors and enhances the yield of retroviral particles.
Gerstmayer B, Groner B, Wels W, Schnierle BS. Gerstmayer B, et al. J Virol Methods. 1999 Aug;81(1-2):71-5. doi: 10.1016/s0166-0934(99)00053-1. J Virol Methods. 1999. PMID: 10488763
Cited by
- Acidity suppresses CD8 + T-cell function by perturbing IL-2, mTORC1, and c-Myc signaling.
Vuillefroy de Silly R, Pericou L, Seijo B, Crespo I, Irving M. Vuillefroy de Silly R, et al. EMBO J. 2024 Sep 16. doi: 10.1038/s44318-024-00235-w. Online ahead of print. EMBO J. 2024. PMID: 39284912 - T-bet deficiency and Hic1 induction override TGF-β-dependency in the formation of CD103+ intestine-resident memory CD8+ T cells.
Wang L, Mishra S, Fan KK, Quon S, Li G, Yu B, Liao W, Liu Y, Zhang X, Qiu Y, Li Y, Goldrath AW, Ma C, Zhang N. Wang L, et al. Cell Rep. 2024 Jun 25;43(6):114258. doi: 10.1016/j.celrep.2024.114258. Epub 2024 May 22. Cell Rep. 2024. PMID: 38781073 Free PMC article. - The DNA damage-independent ATM signalling maintains CBP/DOT1L axis in MLL rearranged acute myeloid leukaemia.
Wang G, Zhang W, Ren J, Zeng Y, Dang X, Tian X, Yu W, Li Z, Ma Y, Yang P, Lu J, Zheng J, Lu B, Xu J, Liang A. Wang G, et al. Oncogene. 2024 Jun;43(25):1900-1916. doi: 10.1038/s41388-024-02998-2. Epub 2024 Apr 26. Oncogene. 2024. PMID: 38671157 Free PMC article. - Recurrent mutations in tumor suppressor FBXW7 bypass Wnt/β-catenin addiction in cancer.
Zhong Z, Virshup DM. Zhong Z, et al. Sci Adv. 2024 Apr 5;10(14):eadk1031. doi: 10.1126/sciadv.adk1031. Epub 2024 Apr 3. Sci Adv. 2024. PMID: 38569029 Free PMC article. - Antigen-independent, autonomous B cell receptor signaling drives activated B cell DLBCL.
Eken JA, Koning MT, Kupcova K, Sepúlveda Yáñez JH, de Groen RAL, Quinten E, Janssen J, van Bergen CAM, Vermaat JSP, Cleven A, Navarrete MA, Ylstra B, de Jong D, Havranek O, Jumaa H, Veelken H. Eken JA, et al. J Exp Med. 2024 May 6;221(5):e20230941. doi: 10.1084/jem.20230941. Epub 2024 Mar 21. J Exp Med. 2024. PMID: 38512136 Free PMC article.
References
- Virology. 1970 Dec;42(4):1136-9 - PubMed
- J Virol. 1992 Aug;66(8):5110-3 - PubMed
- Virology. 1975 May;65(1):128-34 - PubMed
- J Gen Virol. 1977 Jul;36(1):59-74 - PubMed
- J Virol. 1981 Apr;38(1):239-48 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous